Nectar Lifesciences Limited — Others, 26-08-2025: Shareholders meeting

Nectar Lifesciences will hold its 30th Annual General Meeting to address key company matters. Shareholders will consider adopting the financial statements for the recently concluded fiscal year and re-appointing director Mr. Sanjiv Goyal. The Board proposes ratifying the Cost Auditors' remuneration of 0.02 Cr annually and appointing Mr. Prince Chadha as Secretarial Auditor for five years at 0.01 Cr per year. A significant agenda item is the proposed adoption of new Articles of Association, necessitated by an investor's (Isengard Direct PE LLC) share sale, which rescinds their previously held rights. The company also noted that previous unclaimed dividends of 0.0043 Cr and 35,734 shares were transferred to IEPF.